{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T12:31:26Z","timestamp":1763728286656,"version":"3.41.2"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:00:00Z","timestamp":1662422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Enterovirus causing hand-foot-mouth disease (HFMD) has been reported to be associated with the development of Kawasaki disease (KD), whereas the involvement of enterovirus in the clinical course of KD is uncertain. The aim of this study is to investigate the association between the clinical course of KD and HFMD epidemics.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This study included 108 patients who developed KD during HFMD epidemic seasons (July and August) from 2010 to 2014 and who were initially treated with high-dose intravenous immunoglobulin (IVIG). A mean of \u22655.0 HFMD patients reported weekly from each sentinel medical facility was considered to represent a large HFMD epidemic. We compared the clinical characteristics of KD patients in summers of years with and without large HFMD epidemics.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Large HFMD epidemics occurred in 2011 and 2013. The number of KD patients in summer was the highest in 2011. The proportion of patients with resistance to the IVIG therapy in summers of years with the large epidemics (14%) was significantly lower than that in summers of other years (31%, <jats:italic>P<\/jats:italic> = 0.030), whereas the proportion of patients with coronary artery abnormalities did not differ to a statistically significant extent. The development of KD during large HFMD epidemics was significantly associated with a lower risk of resistance to the IVIG therapy (incidence rate ratio 0.92, <jats:italic>P<\/jats:italic> = 0.049).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Patients developing KD during large HFMD epidemic may have good responsiveness to IVIG. It is important to identify microbes from KD patients to predict responsiveness to IVIG therapy.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2022.968857","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T07:43:37Z","timestamp":1662450217000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["The possible association between epidemics of hand-foot-and-mouth disease and responsiveness to immunoglobulin therapy in Kawasaki disease"],"prefix":"10.3389","volume":"10","author":[{"given":"Daisuke","family":"Shimizu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Hoshina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshie","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasufumi","family":"Hidaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masumi","family":"Kojiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Muneuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junji","family":"Kamizono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichiro","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihisa","family":"Fujino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Kusuhara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S0140-6736(04)16814-1","article-title":"Kawasaki syndrome","volume":"364","author":"Burns","year":"2004","journal-title":"Lancet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/cei.12832","article-title":"Kawasaki disease: a matter of innate immunity","volume":"186","author":"Hara","year":"2016","journal-title":"Clin Exp Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.autrev.2009.12.004","article-title":"Kawasaki disease: aetiopathogenesis and therapeutic utility of intravenous immunoglobulin","volume":"9","author":"Galeotti","year":"2010","journal-title":"Autoimmun Rev."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e74529","DOI":"10.1371\/journal.pone.0074529","article-title":"Seasonality of Kawasaki disease: a global perspective","volume":"8","author":"Burns","year":"2013","journal-title":"PLoS ONE."},{"key":"B5","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/ped.13809","article-title":"Nationwide epidemiologic survey of Kawasaki disease in Japan, 2015-2016","volume":"61","author":"Makino","year":"2019","journal-title":"Pediatr Int."},{"key":"B6","doi-asserted-by":"publisher","first-page":"7952","DOI":"10.1073\/pnas.1400380111","article-title":"Tropospheric winds from northeastern China carry the etiologic agent of Kawasaki disease from its source to Japan","volume":"111","author":"Rod\u00f3","year":"2014","journal-title":"Proc Natl Acad Sci USA."},{"key":"B7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/tpj.2011.45","article-title":"ITPKC and CASP3 polymorphisms and risks for IVIG unresponsiveness and coronary artery lesion formation in Kawasaki disease.","volume":"13","author":"Onouchi","year":"2013","journal-title":"Pharmacogenomics J"},{"key":"B8","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1161\/CIRCGENETICS.116.001533","article-title":"Genetic variation in the SLC8A1 calcium signaling pathway is associated with susceptibility to Kawasaki Disease and coronary artery abnormalities","volume":"9","author":"Shimizu","year":"2016","journal-title":"Circ Cardiovasc Genet."},{"key":"B9","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1136\/archdischild-2018-315267","article-title":"Seasonality in clinical courses of Kawasaki disease","volume":"104","author":"Shimizu","year":"2019","journal-title":"Arch Dis Child."},{"key":"B10","unstructured":"City of Kitakyushu"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e678","DOI":"10.1542\/peds.2004-0726","article-title":"Epidemiologic features of Kawasaki disease in Taiwan, 1996-2002","volume":"114","author":"Chang","year":"2004","journal-title":"Pediatrics."},{"key":"B12","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jfma.2013.12.008","article-title":"Viral infections associated with Kawasaki disease","volume":"113","author":"Chang","year":"2014","journal-title":"J Formos Med Assoc."},{"key":"B13","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/INF.0000000000001748","article-title":"Enterovirus infection and subsequent risk of Kawasaki Disease: a population-based cohort study","volume":"37","author":"Weng","year":"2018","journal-title":"Pediatr Infect Dis J."},{"key":"B14","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/j.1442-200x.2005.02033.x","article-title":"Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition)","volume":"47","author":"Ayusawa","year":"2005","journal-title":"Pediatr Int."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1161\/CIRCULATIONAHA.105.592865","article-title":"Prediction of intravenous immunoglobulinunresponsiveness in patients with Kawasaki disease","volume":"113","author":"Kobayashi","year":"2006","journal-title":"Circulation."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1253\/circj.CJ-66-0096","article-title":"Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2013). Digest version","volume":"78","year":"2014","journal-title":"Circ J"},{"key":"B17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jpeds.2020.05.034","article-title":"Epidemiology, treatments, and cardiac complications in patients with Kawasaki Disease: The nationwide survey in Japan, 2017-2018","volume":"225","author":"Ae","year":"2020","journal-title":"J Pediatr"},{"key":"B18","unstructured":"City of Kitakyushu (in Japanese)"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1093\/clinids\/20.5.1201","article-title":"Neonatal enterovirus infection: virology, serology, and effects of intravenous immune globulin","volume":"20","author":"Abzug","year":"1995","journal-title":"Clin Infect Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jcv.2015.06.086","article-title":"Neutralization of Enterovirus D68 isolated from the 2014 US outbreak by commercial intravenous immune globulin products","volume":"69","author":"Zhang","year":"2015","journal-title":"J Clin Virol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3389\/fped.2020.00323","article-title":"Prevalence and management of severe hand, foot, and mouth disease in Xiangyang, China, from 2008 to 2013","volume":"8","author":"Liu","year":"2020","journal-title":"Front Pediatr."},{"key":"B22","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1046\/j.1469-0691.2000.00173.x","article-title":"Enterovirus antibody titers after IVIG replacement in agammaglobulinemic children","volume":"6","author":"Galama","year":"2000","journal-title":"Clin Microbiol Infect."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1056\/NEJM200005253422113","article-title":"Regional enteritis associated with enterovirus in a patient with X-linked agammaglobulinemia","volume":"342","author":"Cellier","year":"2000","journal-title":"N Engl J Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"216","DOI":"10.2188\/jea.JE20110126","article-title":"Epidemiologic features of Kawasaki disease in Japan: results of the 2009-2010 nationwide survey","volume":"22","author":"Nakamura","year":"2012","journal-title":"J Epidemiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"250","DOI":"10.4070\/kcj.2014.44.4.250","article-title":"Evaluation of the temporal association between Kawasaki Disease and viral infections in South Korea","volume":"44","author":"Kim","year":"2014","journal-title":"Korean Circ J."},{"key":"B26","doi-asserted-by":"publisher","first-page":"607631","DOI":"10.3389\/fped.2020.607631","article-title":"C-reactive protein to albumin ratio for predicting coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease","volume":"8","author":"Tsai","year":"2020","journal-title":"Front Pediatr."},{"key":"B27","doi-asserted-by":"publisher","first-page":"442","DOI":"10.3389\/fped.2020.00442","article-title":"Use of adjunctive therapy in acute Kawasaki disease in Latin America","volume":"8","author":"Fortuna-Reyna","year":"2020","journal-title":"Front Pediatr."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.2166\/wh.2015.130","article-title":"A positive association between cryptosporidiosis notifications and ambient temperature, Victoria, Australia, 2001-2009","volume":"13","author":"Kent","year":"2015","journal-title":"J Water Health."},{"key":"B29","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.jaci.2016.04.062","article-title":"Airborne dust and high temperatures are risk factors for invasive bacterial disease","volume":"139","author":"Jusot","year":"2017","journal-title":"J Allergy Clin Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1574-6976.2006.00047.x","article-title":"Microarray analyses of meningococcal genome composition and gene regulation: a review of the recent literature","volume":"31","author":"Claus","year":"2007","journal-title":"FEMS Microbiol Rev."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.968857\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T07:43:40Z","timestamp":1662450220000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.968857\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,6]]},"references-count":30,"alternative-id":["10.3389\/fped.2022.968857"],"URL":"https:\/\/doi.org\/10.3389\/fped.2022.968857","relation":{},"ISSN":["2296-2360"],"issn-type":[{"type":"electronic","value":"2296-2360"}],"subject":[],"published":{"date-parts":[[2022,9,6]]},"article-number":"968857"}}